Range Low Price High Price Comment
30 days $0.390 $0.455 Wednesday, 1st May 2024 NBSE stock ended at $0.416. This is 0.0962% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 0% from a day low at $0.416 to a day high of $0.416.
90 days $0.390 $1.15
52 weeks $0.139 $4.44

Historical Neubase Therapeutics Inc prices

Date Open High Low Close Volume
May 01, 2024 $0.416 $0.416 $0.416 $0.416 1 172
Apr 30, 2024 $0.418 $0.440 $0.411 $0.416 8 846
Apr 29, 2024 $0.422 $0.431 $0.411 $0.418 9 441
Apr 26, 2024 $0.430 $0.450 $0.412 $0.440 72 156
Apr 25, 2024 $0.428 $0.449 $0.428 $0.442 25 440
Apr 24, 2024 $0.448 $0.449 $0.421 $0.421 21 195
Apr 23, 2024 $0.411 $0.447 $0.400 $0.421 58 233
Apr 22, 2024 $0.416 $0.420 $0.401 $0.420 157 786
Apr 19, 2024 $0.411 $0.433 $0.410 $0.430 88 780
Apr 18, 2024 $0.415 $0.440 $0.410 $0.434 47 875
Apr 17, 2024 $0.430 $0.430 $0.401 $0.420 30 884
Apr 16, 2024 $0.419 $0.421 $0.401 $0.402 68 248
Apr 15, 2024 $0.450 $0.450 $0.413 $0.417 34 973
Apr 12, 2024 $0.410 $0.439 $0.400 $0.439 71 332
Apr 11, 2024 $0.419 $0.419 $0.400 $0.410 13 064
Apr 10, 2024 $0.391 $0.415 $0.391 $0.401 52 966
Apr 09, 2024 $0.393 $0.414 $0.391 $0.395 48 845
Apr 08, 2024 $0.419 $0.420 $0.392 $0.407 45 430
Apr 05, 2024 $0.435 $0.435 $0.390 $0.400 116 618
Apr 04, 2024 $0.449 $0.449 $0.423 $0.430 51 409
Apr 03, 2024 $0.426 $0.449 $0.411 $0.449 214 291
Apr 02, 2024 $0.432 $0.445 $0.415 $0.426 86 879
Apr 01, 2024 $0.445 $0.455 $0.430 $0.440 78 663
Mar 28, 2024 $0.425 $0.450 $0.403 $0.450 282 210
Mar 27, 2024 $0.480 $0.481 $0.415 $0.435 644 721
Click to get the best stock tips daily for free!

About Neubase Therapeutics Inc

Neubase Therapeutics NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its lead programs include NT0100... NBSE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT